The efficacy of dexamethasone alone or in combination with a serotonergic antagonist to prevent nausea and vomiting in laparoscopic cholecystectomy is well established, but few data exist regarding its effects on perioperative cortisol and glucose levels.
The safety and efficacy of dexamethasone alone or in combination with a serotonergic antagonist to prevent nausea and vomiting in laparoscopic cholecystectomy is well established [1] [2] [3] [4] [5] . However, corticosteroids are well known to have significant complications including hypothalamic-pituitaryadrenal axis suppression and hyperglycaemia 6 . Serum cortisol and glucose levels rise in response to laparoscopic cholecystectomy 7-10 , similar to the neuroendocrine response in open cholecystectomy [9] [10] [11] . Dexamethasone causes impaired glucose tolerance in obese patients undergoing surgery 12 , yet there are very little published data on the effects of anti-emetic doses of dexamethasone on plasma cortisol and glucose in the perioperative period. Given the key role cortisol plays in cardiovascular function, mobilisation of energy sources, tissue repair, response to catecholamines and immunomodulation, high doses of a potent exogenous glucocorticoid could significantly impact on patient morbidity and mortality 13 .
This study was designed to assess the effect of anti-emetic perioperative dexamethasone on postoperative cortisol and glucose responses in patients having elective laparoscopic cholecystectomy. We hypothesised that the use of dexamethasone would suppress plasma cortisol postoperatively for at least 24 hours and potentially result in mild hyperglycaemia.
METHODS
After approval from the St Vincent's Hospital Human Research and Ethics Committee, 14 patients having laparoscopic cholecystectomy were prospectively enrolled in this study. Patients with diabetes and those already on glucocorticoids or immunosuppressants for other reasons were excluded.
All patients were studied during morning surgery to minimise diurnal variation in baseline cortisol. Using computer-generated random numbers, patients were randomised to two groups: the dexamethasone group or the placebo group. Patients in the dexamethasone group received dexamethasone 8 mg intravenously and tropisetron 2 mg intravenously at induction. Patients in the placebo group received placebo (normal saline 2 ml) and tropisetron 2 mg at induction. The patient and investigators were blinded until study completion, with only the supervising anaesthetist aware of randomisation data.
All patients received standardised relaxant general anaesthesia with propofol, fentanyl and a neuromuscular blocking agent of the anaesthetist's choice at induction. Anaesthesia was maintained with sevoflurane in oxygen and air. Paracetamol, fentanyl and morphine were used for intraoperative analgesia with other analgesic agents at the discretion of the anaesthetist. Patients received 1000 to 2000 ml of lactated Ringer's solution at the discretion of the anaesthetist.
Blood was taken from each patient pre-induction, five hours post-procedure and then 24 hours postprocedure for total cortisol and glucose levels.
Serum cortisol was measured by a competitive electrochemiluminescence immunoassay using a Modular Analytics E170 (Roche Diagnostics, Mannheim, Germany). The sensitivity was 9 nmol.l -1 . The intra-assay coefficient of variation (CV) was 1.7% for cortisol at 129 nmol.l -1 . The inter-assay CV was 4.7% for cortisol at 102 nmol.l -1 and 2.0% for cortisol at 940 nmol.l -1 .
Plasma glucose was measured by a spectrophotometric-hexokinase method using a Roche Modular analyser (Roche Diagnostics, Mannheim, Germany). The sensitivity was 0.11 mmol.l -1 . The intra-assay CV was 1.0% for glucose at 7.05 mmol.l -1 . The inter-assay CV was 2.3% for glucose at 4.7 mmol.l -1 and 1.8% for glucose at 15.5 mmol.l -1 .
Statistics
An earlier pilot study of four patients was performed with baseline plasma cortisol (mean ± standard deviation) of 391±122 nmol.l -1 and glucose of 5.55±1.6 nmol.l -1 . This showed that a sample size of seven patients in each group would be required to detect a significant change in cortisol at five and 24 hours with a power of 0.80, with a fall to less than 50% of baseline considered significant suppression.
With the small sample size, cortisol and glucose data were not normally distributed and have been expressed as median and 10th to 90th percentile range ( Table 1) .
Glucose and cortisol levels between groups were compared with Mann-Whitney U-Test for nonparametric variables. A two-tailed P value of <0.017 was considered statistically significant, using the Bonferroni correction for multiple comparisons. All analyses were performed using STATA v10.1 (Stata Corp lP, College Station, TX, USA).
RESUlTS
All patients underwent a laparoscopic cholecystectomy with intraoperative cholangiogram. All patients were discharged on the first postoperative day and no postoperative complications occurred. There were no differences with respect to age, gender or body mass between patient groups. There were no significant differences between surgical duration and preoperative albumin levels between groups. No patient had severe renal or hepatic dysfunction.
Median values, the 10th to 90th percentile range and the P values between groups are summarised in Table 1 .
There were no statistically significant differences between groups in baseline cortisol and glucose levels. At five hours, there was no significant difference in plasma cortisol and glucose between the groups. By 24 hours, patients in the dexamethasone group had significantly suppressed cortisol levels (P <0.005) and elevated plasma glucose (P <0.01) compared to the placebo group, with median plasma cortisol in dexamethasone patients less than 5% of the median baseline preoperative value. Surgery is the surgical duration in minutes. Preoperative albumin levels in g/l. C0 and G0 -cortisol and glucose levels at induction. C5 and G5 -cortisol and glucose levels at 5 hours. C24 and G24cortisol and glucose levels at 24 hours.
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DiSCUSSiON
Our study demonstrates that anti-emetic doses of dexamethasone 8 mg intavenously significantly suppress plasma cortisol levels and significantly raise plasma glucose levels 24 hours postoperatively in patients having elective laparoscopic cholecystectomy.
The cortisol response to open and laparoscopic surgery has been well described [7] [8] [9] [10] [11] . Most studies have shown that the cortisol increase is similar in both procedures. it has recently been shown that the enzyme 11ß hydroxysteroid dehydrogenase type 1, which converts inactive cortisone to cortisol, is also up-regulated in skeletal muscle in patients undergoing elective cholecystectomy 8 . This potentially increases tissue levels of active glucocorticoid beyond the period of elevated plasma cortisol levels.
Normal daily cortisol production in humans varies but is in the order of 10 to 20 mg.day -1 in the nonstressed adult and up to 10 to 15 mg.hour -1 during times of extreme stress or illness 14 . Dexamethasone has a potency 25 times greater than cortisol and a duration of action in the order of 72 hours 15 . Thus, an 8 mg dose of dexamethasone is greater than the total cortisol production in a severely ill adult.
There are two significant findings with respect to the cortisol data. First, there was no significant increase in plasma cortisol in the control group at five hours compared to baseline. Plasma cortisol after upper abdominal surgery has been shown to peak at five to six hours 16 , yet only one patient in the control group exhibited a typical stress response at this time point. While several previous studies have demonstrated that the cortisol responses to laparoscopic and open cholecystectomy are similar 10, 17 , others have shown a reduced stress response in magnitude and duration 7, 9 . Our findings suggest that modern surgical and anaesthetic techniques may result in less surgical stress (with respect to activation of the hypothalamic-pituitary-adrenal axis) compared to historical series. Second, in those patients administered dexamethasone, there was no suppression of cortisol at five hours, yet profound suppression occurred at 24 hours. in contrast, an 8 mg intravenous bolus of dexamethasone suppresses normal non-stressed individuals by more than 75% at four hours 18 . This suggests that there remains sufficient surgical stress to overcome the early suppressive effects of the dexamethasone. Future studies examining the duration of ACTH and cortisol suppression beyond 24 hours, utilisation of smaller doses of dexamethasone (e.g. 4 mg) and measurement of total versus free cortisol levels would further clarify the effects of perioperative dexamethasone on the hypothalamic-pituitaryadrenal axis.
Mild hyperglycaemia is a well described response to abdominal surgery including laparoscopic cholecystectomy and this is exacerbated by the use of dexamethasone 12, 19 . Our data show mild elevations in blood glucose at five and 24 hours in the dexamethasone group. No patient had a † * Figure 1 : Cortisol and glucose data displayed graphically with marked reduction in plasma cortisol at 24 hours in the dexamethasone group and minor elevations in plasma glucose. All values expressed as median. * P <0.005. † P <0.01.
glucose elevation severe enough to warrant insulin or alterations in therapy. However, there is the potential for clinically significant hyperglycaemia in subjects with underlying severe insulin resistance or type 2 diabetes 19 and caution should be exercised if planning to use high-dose dexamethasone as an antiemetic in these patient subgroups. All patients were discharged uneventfully at 24 hours, as is usual in our institution. While we demonstrate that plasma cortisol at 24 hours is suppressed and plasma glucose mildly elevated in patients receiving dexamethasone as an antiemetic, there is no evidence from our study that this results in any detrimental effect on the patient. Despite the potential adverse effects associated with dexamethasone administration, two metaanalyses have been unable to show any significant adverse effects in major surgery, trauma or spinal cord injury with high dose methylprednisolone 20 nor with dexamethasone as an anti-emetic 21 . Single doses of corticosteroids do not appear to be harmful in severe sepsis 22 . A larger randomised controlled study specifically evaluating perioperative outcomes with dexamethasone, including wound healing, infection rate and hyperglycaemia, is required to answer these questions.
